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Abstract
An approach for designing individual expression environments that reduce or prevent protein aggregation and
precipitation is described. Inefficient folding of difficult proteins in unfavorable translation environments can cause
significant losses of overexpressed proteins as precipitates or inclusion bodies. A number of chemical chaperones including
alcohols, polyols, polyions or polymers are known to have positive effects on protein stability. However, conventional
expression approaches can use such stabilizing agents only post-translationally during protein extraction and purification.
Proteins that already precipitate inside of the producer cells cannot be addressed. The open nature of cell-free protein
expression systems offers the option to include single chemicals or cocktails of stabilizing compounds already into the
expression environment. We report an approach for systematic screening of stabilizers in order to improve the solubility and
quality of overexpressed proteins co-translationally. A comprehensive list of representative protein stabilizers from the
major groups of naturally occurring chemical chaperones has been analyzed and their concentration ranges tolerated by
cell-free expression systems have been determined. As a proof of concept, we have applied the method to improve the
yield of proteins showing instability and partial precipitation during cell-free synthesis. Stabilizers that co-translationally
improve the solubility and functional folding of human glucosamine 6-phosphate N-acetyltransferase have been identified
and cumulative effects of stabilizers have been studied.
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Introduction
Newly synthesized proteins are at great risk of aberrant folding
already inside the cellular environment. Formation of aggregates
or inclusion bodies composed out of denatured proteins is
commonly observed in particular during overexpression of
proteins [1]. In addition, protein denaturation could result from
degradation mechanisms such as deamidation or oxidation. While
refolding can sometimes help to rescue proteins, often high
amounts of sample are lost and not useful for further applications.
Living cells can support the stability of proteins by a number of
organic substances known also as chemical chaperones [2]. Upon
recombinant protein production, such chemicals are unfortunately
only of limited value as access to the inner cell compartment in
conventional cell-based expression systems is restricted. Increasing
intracellular concentrations of stabilizers by e.g. inducing specific
solute transporters requires strong impacts such as osmotic shocks
which could cause dramatic changes in cell physiology and
expression patterns [3,4]. Stabilization strategies are therefore
usually confined to manipulations of growth conditions or to
attempts of post-translational stabilization during protein extrac-
tion, when significant protein precipitation might already have
occurred. Cell-free (CF) expression systems offer the new option to
support the stability of expressed proteins already co-translation-
ally with a wide and diverse range of additives, while on the other
hand being relatively sensitive to manipulations of reaction
conditions such as incubation temperature. The open nature of
CF reactions allows to supply any tolerated chemical directly into
the protein expression environment [5]. Production protocols for
unstable and difficult proteins can therefore be individually
designed and stabilizers or mixtures thereof can be adjusted
according to specific requirements.
Protein stabilizing agents comprise a wide range of chemicals
including alcohols and molecular crowding agents such as
polyethylenglycols (PEG). Many organisms accumulate small
organic molecules in stress situations, which are generally called
osmolytes [6,7]. Those solutes act as chemical chaperones in the
cell by preventing protein unfolding and improving protein
thermostability. Major groups of osmolytes are polyols, amino
acids, polyions or urea [2]. Prominent examples are the synthesis
of betaine or trehalose in E. coli, glycerol in Saccharomyces cerevisiae
and generally a number of different polyols and amino acid
derivatives in yeasts and plants [7]. Hyperthermophilic microor-
ganisms accumulate organic solutes such as betaine, ectoine or
trehalose in high concentrations while responding to heat stress
[8,9]. The intracellular concentration of some of these compounds
can even reach molar levels dependent on medium osmolality and
growth conditions [10].
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applied for the expression of target libraries [11–13], protein
evolution [14] or drug screening [15]. We have established a
process based on extracts of E. coli cells and on the batch
configuration that allows the screening of chemical chaperones.
The tolerated concentration ranges of all additives were
determined in linear screening schemes and by using shifted
green fluorescent protein (sGFP) as expression monitor. Additives
showing positive effects on sGFP fluorescence were then further
analyzed in linear or in correlated screening schemes for their
effects on two unstable proteins. The screening process for co-
translational protein stabilization was exemplified with the human
glucosamine 6-phosphate N-acetyltransferase (GNA1) and with
the halogenase domain of the fungal CurA polyketide synthetase
[16]. Improved solubility of the two proteins was in particular
monitored with choline and L-arginine and cumulative effects of
selected compounds were analyzed in correlated screens. The
established process could provide guidelines and options for the
preparative scale production of unstable proteins as well as for
exploiting the stabilizing role of osmolytes for biotechnology
purposes.
Materials and Methods
Chemicals
PEG 6000 was obtained from Applichem (Darmstadt, Ger-
many). All other chemicals were from Sigma-Aldrich (Tauf-
kirchen, Germany) and obtained at highest purity.
DNA Templates
Shifted green fluorescence protein (sGFP) was cloned into the
pIVEX 2.3d vector and expressed with a C-terminal poly(His)10
tag using restriction free cloning. The coding region of human
GNA1 (GenBank access code BC012179.1) was first cloned into
the vector pET21a. A C-terminal fusion of sGFP to GNA1 was
then constructed by restriction free cloning. The forward primer
had a 24 base overlap complementary to the 59 end of the desired
insertion site of the vector and followed by a start codon and 20–
25 bases of the 59 end of GNA1 coding sequence. The reverse
primer annealed to the vector with 24 bases complementary to the
39 end of the insertion site. A pair of primers was furthermore
designed in order to fuse the TEV-sGFP gene sequence after the
GNA1 gene sequence (Table 1). The CurA halogenase domain
was cloned into the vector pET28b (Merck Bioscience, Darmstadt,
Germany) and expressed with an N-terminal His6-tag. The native
protein sequence covers the amino acids 1599 to 1930 of CurA
according to the sequence accessible at NCBI (GenBank accession
code: AAT70096.1). DNA templates used for CF expression were
transformed into E. coli strain DH5a and isolated by standard
plasmid purification kits (Macherey-Nagel, Du ¨ren, Germany).
Table 1. Construction of DNA templates.
Construct Vector Modification Primer sequence
1
sGFP pIVEX
2.3d
C-poly(His)10 F: TTTTGTTTAACTTTAAGAAGGAGATATAC ATATGAGCAAAGGAGAAGAACTTTTCAC
R: GTGGTGGTGGTGGTGGTGGTGGTGGGATC CCTCGAGTGCGGCCGCAAGCTTTTTGTA
GNA1 pET21a C-poly(His)6 F: CGCGGATCCATGAAACCTGATGAAACTCCT
R: CCGCTCGAGCTTTAGAAACCTCCGACACA
GNA1-sGFP pET21a C-poly(His)10 TEV cleavage F: CTACATGTGTCGGAGGTTTCTAAAGGGCG AAAACCTGTACTTCCAGGGCG
R: GGTGGTGGTGGTGGTGGTGCTCGAGTGCG GCCGCAAGCTTTTTGTAGAGC
CurA- Halogenase pET28b N-poly(His)6 F: TCATGCCATATGCCAAAAACTATGA ACCGGGA
R: TCATCGCTCGAGTTATTAGATGCTTG GTGTTTCC
1F: Forward; R: Reverse.
doi:10.1371/journal.pone.0056637.t001
Table 2. CF reaction protocol for compound screening.
Compound Stock Final Range
Premix: 10-fold 1-fold
Putrescine 15 mM 1.5 mM
Spermidine 15 mM 1.5 mM
K
+-glutamate 2500 mM 250 mM
NH4
+-glutamate 100 mM 10 mM 10–30 mM
Mg
2+-glutamate 100 mM 10 mM
1
Na
+-oxalate 40 mM 4 mM
Na
+-pyruvate 330 mM 33 mM
Folinic acid 340 mg/ml 34 mg/ml
DTT 10 mM 1 mM
NAD
+ 5.3 mM 0.53 mM
Individual compounds:
20 amino acid mix 8 mM each 2 mM each
PEP-K
+ 1 M 30 mM
CoA-Na
+ 30 mM 0.26 mM
E. coli tRNA 40 mg/ml 0.17 mg/ml
T7-RNA-polymerase 1.4 mg/ml 10 mg/ml 5–10 mg/ml
NTP-Mix: ATP 90 mM 2.5 mM
NTP-Mix: C/G/UTP (each) 60 mM 1.7 mM
DTT 500 mM optional 1–10 mM
Plasmid template 0.3 mg/ml 0.015 mg/ml
E. coli S30 extract 100% 24% or 31%
2 22–35%
Mg
2+-glutamate 100 mM 16 mM
1 20–30 mM
1
H2O fill up to 25 ml
1if not used as screening compound, the total final Mg
2+ concentration was
adjusted to 26 mM.
224% were used for analytical scale screening reactions, whereas 31% were
used for preparative scale reactions.
doi:10.1371/journal.pone.0056637.t002
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Batch CF reactions were performed in 96 well V-shape
microplates (PS-microplate 96 well V-shape, Greiner Bio-One,
Frickenhausen, Germany) in a final reaction volume of 25 mla ta
temperature of 30uC and with gentle shaking. The basic reaction
mixture (RM) contained 2.5 mM ATP, 1.7 mM each of GTP,
UTP and CTP, 34 mg/ml folinic acid, 170 mg/ml E. coli tRNA
mixture (Roche, Penzberg, Germany), 4–15 ng/ml of plasmid
template DNA, 10 mg/ml T7 RNA polymerase, 2 mM each of the
20 proteinogenic amino acids, 0.53 mM NAD
+, 0.26 mM CoA,
280 mM K
+-glutamate, 10 mM NH4
+-glutamate, 10 mM Mg
2+-
glutamate, 1.5 mM spermidine, 1.5 mM putrescine, 4 mM Na
+-
oxalate, 1 mM DTT and 0.24% (v/v) of S30 extract in analytical
scale reactions or 31% (v/v) in preparative scale reactions (Table 2)
[5]. If Mg
2+ ions were not analyzed as screening reagent, the final
Mg
2+ concentration of the reaction was adjusted to 26 mM with
Mg
2+-glutamate. The 10-fold premix prepared for screening
reactions contained 15 mM putrescine, 15 mM spermidine,
2.5 M K
+-glutamate, 100 mM NH4
+-glutamate, 100 mM Mg
2+-
glutamate, 40 mM Na
+-oxalate, 330 mM Na
+-pyruvate, 340 mg/
ml folinic acid, 10 mM DTT, 5.3 mM NAD
+(Table 2). The
premix could be stored at 220uC and refrozen multiple times
without detectable loss of efficiency.
Compound Screening
Batch reactions were pipetted with a Tecan Freedom EVO 200
device equipped with an eight channel liquid handling arm
(461,000 ml and 4650 ml syringes) and two transport arms
(Tecan, Ma ¨nnedorf/Zu ¨rich, Switzerland). The pipetting range
was in between 300 nl and 800 ml. Stock solutions of chemicals
(Sigma-Aldrich, Steinheim, Germany) were prepared in either
H2O or 500 mM HEPES-KOH buffer, pH 8.2, and kept on
cooling carriers at 4uC upon pipetting. All additives were adjusted
prior addition to pH 8.2 by titration with either 500 mM HEPES-
KOH, pH 8.2, or with 100 mM L-glutamic acid.
Linear concentration screening of selected single compounds as
well as correlated concentration screening of two compounds was
programmed by the custom designed EYES software based on the
Figure 1. Linear concentration screens of basic CF batch
reaction compounds. Expression efficiency was determined by sGFP
fluorescence. A: Basic compounds S30 extract, DTT, NH4
+,M g
2+;B :
Plasmid templates.
doi:10.1371/journal.pone.0056637.g001
Figure 2. Correlated concentration screens with Mg
2+ ions. Expression efficiency was determined by sGFP fluorescence. A: NTP mix/Mg
2+;B :
PEP/Mg
2+.
doi:10.1371/journal.pone.0056637.g002
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each reaction compound was calculated and liquid classes for
proper pipetting were defined. A mastermix of common
compounds was then prepared and the screening compounds
were pipetted first into the individual cavities of 96well micro-
plates, followed by appropriate volumes of the mastermix.
Processing time for calculation and pipetting was approximately
30–45 min per one complete 96well microplate screen. During
pipetting, the microplate was chilled at 4uC and the reactions were
started by addition of template DNA with subsequent incubation
at 30uC on a shaker.
Protein Quantification
Proteins containing red shifted sGFP fusions were quantified by
fluorescence measurement with an excitation wavelength of
484 nm and emission wavelength of 510 nm [5]. Further method
parameters were defined in the TECAN Magellan 5.03 software:
Gain (Manual): 25; Number of reads: 10; Integration time: 40 ms;
Lag time: 0 ms; Mirror selection: automatic; Multiple reads per
well (Circle): 262; Incubation time: 20 s; Settle time: 20 s. Protein
concentration was calculated from the measured sGFP fluores-
cence according to a calibration curve with purified sGFP.
Potential effects of the analyzed chemicals on sGFP were
determined by fluorescence measurements after incubating
aliquots of 300 mg/ml purified sGFP with corresponding chem-
icals at 30uC for 4 hrs.
Alternatively, immunoblotting using anti-His antibodies or
proteins labeled with
35S-methionine were used for quantification.
35S-methionine mixed with non-labeled amino acids in a ratio of
1:40,000 were added into the reaction. After expression, samples
were transferred into reaction tubes, centrifuged at 22,0006g for
10 min and the supernatant was precipitated with 10% trichloric
acid. After washing, the pellet and the precipitated supernatant
were measured for radioactivity. Control experiments without any
DNA template were used as background value for the radioassay.
Activity Assay of GNA1-sGFP
The 50 ml reactions were transferred into D-tubes (Novagen,
Darmstadt, Germany), diluted with 50 ml buffer (50 mM Tris-
HCl, pH 8.0) and dialyzed against 500 ml buffer with stirring at
4uC for 2 hrs. Samples were then centrifuged at 22,0006g for
10 min and supernatants were used for enzyme activity assay. The
assay was performed in 50 ml buffer containing 500 mM D-
glucosamine 6-phosphate (GlcN6P), 500 mM AcCoA, 50 mM
Tris-HCl, pH 8.0, 5.0 mM MgCl2 and 10% glycerol in 96well flat
bottom plates. Approximately 0.4 mg unpurified GNA1-sGFP
(determined by fluorescence) were added to start the reaction.
After incubation at 30uC for 5 min, the reaction was terminated
by adding 50 ml of stop solution (50 mM Tris–HCl, pH 8.0, and
6.4 M guanidine hydrochloride) and then 50 ml of CR buffer
(50 mM Tris–HCl, pH 8.0, 1 mM EDTA, and 200 mM 5,59-
dithiobis(2-nitrobenzoic acid) (DTNB). The amount of CoA
produced by GNA1 was determined by 4-nitrothiophenolate
formation and measured at 412 nm in a microplate reader (Fisher
Scientific, Schwerte, Germany). A blank reaction using CF
reactions without GNA1-sGFP template was used as control.
The amount of CoA produced was calculated using the extinction
coefficient of DTNB at 30uC (13,800 M
21 cm
21).
Results and Discussion
Basic CF Reaction Set Up for Robotic Screening
Applications
The production of fluorescent sGFP was used as fast monitor for
setting up the basic reaction protocol and for the subsequent
evaluation of compound compatibility. In order to reduce
pipetting time, a number of standard reaction compounds
including salts, polyamines and some precursors were combined
in a premix (Table 2). S30 extract, enzymes, unstable reagents and
screening compounds were kept separately. The premix is stable at
280uC for at least one year and remains active after repeated
freeze-thaw cycles [17]. Protein synthesis with the basic batch
protocol is effective over 2 hrs and then reaches a plateau at
production levels of approximately 0.5–0.8 mg sGFP per ml of
batch reaction. Folding of sGFP is oxygen dependent and the
plates were therefore further incubated for 2 hrs after the reaction
prior to fluorescence determination.
Working lists for programming and pipetting were generated by
the specific EYES software and optimal concentration ranges for
several basic compounds were determined by linear or correlated
concentration screening (Table 2). The S30 extract had a well-
defined optimum at approximately 31% final concentration
(Fig. 1A). Mg
2+ ions are known to be critical for CF reactions
Figure 3. Effect of PEG and alcohols on fluorescent sGFP
expression in the CF batch configuration. The first bar of each set
indicates the control without added compound. Data are averages of at
least three determinations. A: Screening of PEGs of different molecular
weight. The sGFP protein control was 600–750 mg/ml. B: Effect of
alcohols. The sGFP protein control was approximately 500 mg/ml.
doi:10.1371/journal.pone.0056637.g003
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20–28 mM depending on the S30 extract preparation. Reducing
conditions could become important depending on the nature of
the synthesized target proteins. DTT as reducing agent is tolerated
in the reaction at least up to 10 mM final concentration while it
could also be completely omitted without significant effects. NH4
+
ions were tolerated at least up to 30 mM final concentration
(Fig. 1A). Protein expression increased with plasmid DNA
template concentrations up to 2–4 ng/ml reaction and then
remained at a relatively stable plateau. The DNA template
concentration optimum appeared to be independent from the
coding regions of sGFP or GNA1-sGFP (Fig. 1B).
Mg
2+ ions could interact with other negatively charged
compounds of the reaction such as NTPs or PEP and correlated
optimal concentration ranges were analyzed (Fig. 2). With the
combination of NTP mix and Mg
2+, optimal efficiency was
determined within the range of 1–2 fold NTP mix and 20–26 mM
Mg
2+ (Fig. 2A). With the combination of PEP and Mg
2+, optimal
concentrations were ranging from 36–50 mM and 24–30 mM,
respectively (Fig. 2B). After establishing reaction conditions, the
protein production in the CF batch reaction could be scaled up to
at least 1 ml reaction volumes without loss of efficiency.
PEG Derivatives as CF Additives
PEG derivatives are known to act as molecular crowding agents
by binding water thus making other reaction compounds more
readily accessible. PEGs with increasing average molecular
weights starting from 200 up to 8,000 kDa were added and with
the exception of PEG 400 resulted into an increased sGFP
fluorescence of 10–20% at final concentrations of 2–3% (Fig. 3A).
The addition of PEG 10,000 resulted into an instant precipitation
of reaction components presumably due to protein denaturation.
PEG and other molecular crowding agents have been used to
condense reactants and to mimic cellular environments in CF
systems based on wheat germ extracts [18,19]. A more detailed
study revealed that PEG 8,000 resulted into increased CF
transcription but rather reduced CF translation [18] and also
different effects correlated with the PEG molecular weight on
proteins are known [20]. However, systematic analysis of PEGs
with different molecular weights in CF systems have not been
made yet.
Alcohols as CF Additives
Organic solvents are usually denaturizing by disrupting
hydrophobic contacts in between the nonpolar side chains of
amino acids. These effects are concentration dependent and some
solvents such as alcohols or ketones can even act as protein
stabilizers at lower concentrations while they convert to denatur-
ants at high concentrations [21]. A further important parameter
for stabilizing effects is the chain length of alcohols. We have
analyzed alcohols of chain lengths from one to six carbon atoms
for their compatibility with our CF system and for their effects on
sGFP fluorescence (Fig. 3B). With the exception of ethanol, all
other analyzed alcohols had concentration dependent negative
effects on sGFP fluorescence most likely due to inhibition of factors
essential for the basic protein expression machinery [22]. With
pentanol and hexanol, already the lowest supplied concentration
resulted in almost complete inhibition of sGFP expression and
precipitate formation indicated substantial denaturation of pro-
teins from the S30 extract. Addition of ethanol at 6–8% final
concentration resulted into an 60% increase of sGFP fluorescence
corresponding to an expression of approximately 800 mg/ml
(Fig. 3B).
Our results are consistent with previous observations that
denaturation effects of alcohols are correlated with their chain
length and concentration. Low concentrations of ethanol in
between 0.1–2.5% stabilized proteins and inhibited the mechan-
ical denaturation of hemoglobin or the degradation of cytosolic
proteins [23]. In the E. coli CF system, ethanol appears to be most
promising in promoting protein expression as a result of either
stabilizing the expression machinery and/or improving the folding
of sGFP. Methanol, isopropanol and butanol had only minor
Table 3. Compatibility of protein stabilizing compounds to the CF system.
Class Compound sGFP
1 Working range
2 Class Compound sGFP
1 Working range
2
Polyions Betaine 6 .250 mM Amino acids L-OH- proline ++ .10 mM
Choline ++ .20 mM N-acetyl-L- lysine + ,100 mM
Ectoine 6 ,150 mM L-carnitine ++ ,10 mM
Polyols Sucrose 6 #10% L-arginine ++ .20 mM
Glycerol 6 ,8% Sarcosine + .40 mM
D-trehalose 6 ,4% L-glutamic- acid ++ .400 mM
3
D-mannose 6 ,2% Alcohols Methanol + #5%
D-sorbitol 6 ,4% Ethanol + #8%
PEGs PEG 200 + .6% Isopropanol 6 #5%
PEG 400 6 ,4% Butanol 6 #3%
PEG 1,000 + ,6% Pentanol - ,1%
PEG 6,000 + ,4.8% Hexanol - ,1%
PEG 8,000 + ,4.8% Others PEI 2,000 - ,0.001%
PEG 10,000 6 ,1% Urea 6 ,100 mM
1effect on fluorescent sGFP expression: 6, tolerated over a certain concentration range; -, decrease in fluorescent sGFP expression;+and ++, increase in fluorescent sGFP
expression.
2working range is defined with no more than 20% decrease in fluorescent sGFP expression. At the indicated concentration limits, the analyzed chemicals have either no
effect or a slight quenching effect of maximal 10% on sGFP fluorescence.
3used as basic buffer compound.
doi:10.1371/journal.pone.0056637.t003
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concentration. Alcohols are frequently used in combination with
detergents in order to stabilize hydrophobic membrane proteins in
crystallization studies. The CF compatible alcohols might thus be
considered as potential stabilizers of these protein types in future
expression approaches.
Natural Cellular Stabilizers as CF Additives
Living cells can produce a number of small molecules in order
to stabilize intracellular proteins in extreme environmental
conditions [10]. The major classes of these compounds are (i)
polyols/sugars, (ii) amino acids and (iii) polyions. Polyols can
protect proteins against a variety of denaturation and degradation
mechanisms including aggregation, thermal denaturation, deam-
idation and oxidation [24,25]. Further applications are preventing
protein dehydration upon freeze-drying by serving as water
substituent through hydrogen bonding. Sucrose and glycerol have
become standard stabilizers for the long-term storage of protein
samples. Protein protection by individual polyols can act in
different ways and even mixtures might therefore be considered
for optimal effects [26]. Amongst the most frequent polyols
synthesized in various organisms are sucrose, glycerol, D-trehalose,
D-mannose or D-sorbitol [27]. For lysozyme, D-mannitol was
found to prevent aggregation, sucrose acted against deamidation
and lactose reduced oxidation [28].
We have analyzed the compatibility of glycerol, sucrose, D-
sorbitol, D-trehalose and D-mannose for our CF system by
monitoring fluorescent sGFP expression (Table 3). D-sorbitol, D-
trehalose and D-mannose were dose dependent inhibitors of
fluorescent sGFP production starting already at 1% final
concentration in the reaction (Fig. 4A). In contrast, sucrose and
glycerol are tolerated up to 8% and 4% final concentration,
respectively. Both compounds could thus be considered as
potential CF additives in the determined tolerated concentration
ranges.
Amino acids can have a dual role in CF expression systems as
they primarily serve as substrater for translation, but also could
help to stabilize the expression machinery and/or the synthesized
target protein. Proteinogenic amino acids such as L-arginine and
L-glutamic acid in addition to some non-proteinogenic amino
acids such as trans-OH-L-proline, N-acetyl-L-lysine and L-
carnitine are known as protein stabilizers in vitro [29] and the
concentration ranges compatible to the CF system were
determined by fluorescent sGFP monitoring (Fig. 4B). Overall,
all tested amino acids showed beneficial effects with some 10–20%
increased sGFP fluorescence. The concentration optima were
different and ranging from 50–80 mM for glutamic acid, 20–
90 mM for trans-OH-L-proline, 20–50 mM for L-arginine, 30–
50 mM for N-acetyl-L-lysine, 30–50 mM for L-carnitine and 50–
70 mM for sarcosine. In particular N-acetyl-L-lysine and L-
carnitine rapidly inhibit sGFP expression above their optimal
concentrations while the concentration optima of the other amino
acids have a more Gaussian appearance.
The polyions betaine, choline and ectoine are synthesized by
organisms living in extremophile environments for the stabilization
of cytoplasmic proteins. However, even E. coli is able to synthesize
high amounts of betaine under some conditions [30]. Stabilizing
effects have been shown with the inhibition of the in vitro insulin
amyloid formation by ectoine or betaine [25]. For betaine and
ectoine, a high tolerance of up to approximately 150 mM and
100 mM was determined in the CF system (Fig. 4C). However,
neither compound had a positive effect on sGFP fluorescence. In
contrast, an approximately 30% increased sGFP fluorescence was
measured in presence of 4–14 mM choline. The general
Figure 4. Effect of potential protein stabilizers on fluorescent
sGFP expression in the CF batch configuration. The first bar of
each set indicates the control without added compound and with sGFP
production of approximately 500 mg/ml reaction. Data are averages of
at least three determinations. A: Polyols; B: Amino acids; C: Polyions.
doi:10.1371/journal.pone.0056637.g004
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polyions and below approximately 30 mM final concentration.
Improving the Soluble CF Expression of Human GNA1
and of CurA Halogenase by Addition of Stabilizers
As a first proof of principle, we approached to improve the CF
expression of two targets known to partly precipitate as aggregates.
Figure 5. Effect of potential stabilizers on the quality of CF expressed sGFP and GNA1-sGFP. A: Choline or L-arginine were added at final
concentrations of 10 mM each. Controls without any additives were taken as 100%. Soluble protein expression was measured by sGFP fluorescence,
total protein production was quantified by
35S-Met incorporation and functional folding of GNA1 was analyzed by enzymatic activity. F, fluorescence;
T, total protein production; E, enzymatic activity. B: Correlated screening of PEG 8,000 and choline for fluorescent expression of GNA1-sGFP. Controls
without any additives were taken as 100%. Black, 160–180%; Dots, 120–160%; Lines, 80–120%; Gray, 0–80%.
doi:10.1371/journal.pone.0056637.g005
Figure 6. Effect of protein stabilizers on the soluble expression of CurA halogenase. The CurA halogenase domain was expressed in the
batch configuration with different additives. Protein production was quantified by immunoblotting. The results were normalized with the control as
100% corresponding to a protein concentration of 80 ng/ml. A: Immunoblot with anti-penta-His antibody. M, marker proteins in kDa; P, positive
control for quantification (Positope
TM, invitrogene). B: Quantification of band intensity. 1, control; 2, 6% D-trehalose; 3, 10 mM L-arginine; 4, 10 mM
choline.
doi:10.1371/journal.pone.0056637.g006
Chemical Chaperones for Improving Protein Quality
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is required for the de novo synthesis of N-acetyl-D-glucosamine-6-
phosphate representing an essential precursor in UDP-GlcNAc
biosynthesis [31]. The protein was synthesized with a C-terminal
fusion to sGFP. The 40.5 kDa halogenase domain of the
polyketide synthetase CurA from Lynbya majuscula was synthesized
with a N-terminal poly(His)6-tag [16]. Efficient CF expression
protocols for both enzymes have been established with yields
exceeding 1 mg/ml. However, solubility is limited and approxi-
mately 30–50% of the expressed proteins precipitate during the
reaction.
Considering the screening results of the analyzed types of
additives, only representative compounds shown to be tolerated by
the CF system were analyzed for potential stabilizing effects on the
two proteins. The addition of sucrose, D-sorbitol, ectoine or
betaine in the tolerated concentration ranges had no effects on the
soluble expression of GNA1-sGFP as monitored by sGFP
fluorescence (data not shown). However, either 10 mM choline
or 10 mM L-arginine increased the GNA1-sGFP fluorescence by
approximately 20% (Fig. 5A). The addition of choline and L-
arginine could either stabilize the general expression machinery
resulting into higher yields, and/or they could stabilize the
synthesized protein resulting in increased solubility. In order to
investigate the reason for increased GNA1-sGFP fluorescence, the
total protein production in the CF reaction was quantified by
35S-
Met incorporation measurements. In addition, CF sGFP expres-
sion was included as a second reference reaction and the specific
enzymatic activity of GNA1-sGFP was furthermore determined.
The total sGFP expression as determined by
35S-Met incorpora-
tion was increased with either 10 mM L-arginine or 10 mM
choline to 10% and 20%, respectively (Fig. 5A). However, in
contrast with GNA1-sGFP only a slight increase with 10 mM
choline was detectable while even a minor reduction of the total
yield was measured with 10 mM L-arginine. Moreover, the
increase in GNA1-sGFP fluorescence correlated with higher
specific activity of the GNA1 enzyme upon addition of 10 mM
choline into the CF reaction. Choline therefore appears to have
multiple stabilizing effects in the CF expression reaction. The
increased total protein production indicates a basic beneficial
effect on the CF expression machinery that also at least partly
contributes to the increased fluorescence of sGFP and GNA1-
sGFP in the soluble protein fractions. However, an additional
stabilizing effect of choline on the synthesized proteins is measured
by the observed increased specific activity of GNA1. Accordingly,
also the effect of L-arginine on sGFP fluorescence appeared to be
cumulative based on higher expression as well as on better
solubility. This is in accordance with previous observations of
better folding of GFP in presence of L-arginine [32]. Interestingly,
L-arginine increased solubility of GNA1-sGFP but not its total
expression or specific activity. Therefore, even basic beneficial
effects of stabilizers on the CF expression machinery appear to be
template dependent and might be determined by improved
formation of e.g. specific translation initiation complexes.
Choline and L-arginine as individual additives improved the CF
production of soluble GNA1-sGFP for some 10–20%. We
therefore analyzed whether beneficial compounds could have
synergistic effects if added in a cocktail. Surprisingly, the
combination of choline with L-arginine in correlated concentra-
tion screens was not cumulative and even some reduction in
solubility was observed (data not shown). However, correlated
screening of further stabilizer combinations identified a synergistic
effect of choline with PEG 8,000, resulting in 50–60% increased
fluorescent GNA1-sGFP production when a concentration range
of 8–16 mM choline and 2–3% PEG 8,000 was used (Fig. 5B).
This result demonstrates that effects of stabilizer combinations are
hard to predict and underlines the need for a systematic screening
approach.
As a further target, the soluble CF expression of the halogenase
domain of CurA was analyzed (Fig. 6). The reactions were
supplemented with either 10 mM choline, 10 mM L-arginine or
6% D-trehalose and the protein in the supernatant was quantified
after the reaction by immunoblotting. In accordance to the results
obtained with sGFP, the addition of L-arginine and choline again
resulted into 8% and 25% increased soluble expression, while the
presence of D-trehalose was inhibitory.
Conclusions
Small molecules belonging to different groups of natural
chemical chaperones can be added into CF expression reactions
and acting as general or specific stabilizers. This work has defined
the working ranges in CF expression systems for a representative
variety of the most commonly employed chemical chaperones.
The tolerated concentrations of the supplied chemicals by the CF
system are different from those reported from living organisms and
a number of compounds tolerated in vivo became rapidly inhibitory
to the CF expression machinery. As most promising stabilizing
agents for the analyzed proteins we could define ethanol, PEG
derivatives, amino acids and choline. However, additional polyols
and polyions are also tolerated at relatively high concentrations
and might therefore be useful in expression approaches with other
target proteins. We could show that stabilizing effects can depend
on the nature of the target protein as well as on the combination of
several additives. Modes of action of the analyzed stabilizers
include increased expression, better solubility as well as improved
stability and could be exclusive or cumulative. We therefore
propose and have established an empirical screening approach in
order to define the optimal concentration balance of stabilizers in
individual CF protein expression approaches. The presented CF
screening platform will become accessible to the scientific
community in the European INSTRUCT network (www.
structuralbiology.eu).
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